Purpose & when to use

Device Challenge Aerosol testing evaluates sensors, collectors, respiratory-protection products, and mitigation devices against controlled biological or particle-tracer aerosols. ARE Labs uses Collison nebulizers, controlled airflow, environmental logging, and qPCR, ddPCR, or fluorescence quantitation to establish a reference challenge concentration under ISO 17025 controls. When required by the device class, method choices are aligned with applicable ASTM, EN, or 42 CFR frames:

  1. Bioaerosol detector sensitivity mapping for fixed or fieldable instruments, using Collison-generated targets and ISO 17025 reference sampling to define detection limits.
  2. Respiratory-protection product comparisons under ASTM F2299, EN 149, or 42 CFR Part 84 context, using particle counters and tracer aerosols to map penetration and response.
  3. Medical-mask or barrier-device challenge studies aligned to ASTM F2101 or EN 14683, using biological or fluorescent tracers to compare capture performance.
  4. Air-treatment and collector validation under ISO 17025 controls, using chamber or duct releases with reference impingers, filters, and qPCR or ddPCR quantitation.
  5. Alert-logic and false-alarm evaluation for bioaerosol sensors, using defined backgrounds, blanks, and replicate release sequences within an ISO 17025 quality system.

Use this service when device performance must be evaluated against a defined aerosol challenge rather than a nominal specification. Before selecting the method, the study plan defines the target, background, flow field, and reference recovery workflow.

Built for detectors, collectors, and protection devices

Device challenge aerosol studies span products that sense, capture, filter, or reduce bioaerosols and particle tracers. The setup adapts to ISO, ASTM, EN, or 42 CFR expectations without treating every device as the same fixture.

  • DetectorsBioaerosol sensors and alarms
  • CollectorsSamplers and capture devices
  • RespiratorsFiltering facepiece programs
  • Medical masksBarrier and BFE studies
  • Air cleanersRoom and duct mitigation

Instrumentation & measurement ranges

The challenge design is based on the target aerosol, device inlet geometry, environmental sensitivity, and reference quantitation endpoint.

1 - 1000 L/minchallenge-flow

Collison and related nebulizers

Generate controlled biological, surrogate, or particle-tracer aerosols into a chamber, duct, or device inlet with release rate documented for each condition.

20 - 80 RHcondition-control

Environmental and airflow control

Flow, temperature, and relative humidity are logged through each challenge so detector response and recovery can be interpreted against the exposure environment.

0.5 - 30 L/minsampler-flow

Inline reference samplers

Impingers, filter holders, or capture trains collect reference aerosol at defined locations and intervals for recovery, blanks, and concentration calculation.

10 - 100000000 copiesquantitation

qPCR, ddPCR, and fluorescence endpoints

Biological and fluorescent tracer quantitation converts collected challenge material into reference concentration, recovery, and dose-response inputs.

Test method options

MethodStrengthsTradeoffAligned with
Detector dose-response mapping
  • Defines limit of detection, response curve, and usable alert threshold for bioaerosol detectors under ISO 17025 records.
  • Pairs device output with reference sampler recovery so algorithm tuning is based on measured challenge concentration.
Requires multiple concentrations, blanks, and replicates, so test time grows with each target organism or surrogate.
ISO 17025
Respiratory-protection particle challenge
  • Supports respirator and filtration-media comparisons using ASTM F2299, EN 149, or 42 CFR Part 84 aerosol challenge context.
  • Reports penetration or device response alongside pressure, flow, and environmental records for design or supplier decisions.
Fixture sealing, face velocity, and challenge aerosol selection must be locked before data can be compared across products.
ASTM F2299EN 14942 CFR Part 84
Medical-barrier bioaerosol challenge
  • Aligns medical mask and barrier-device studies to ASTM F2101 or EN 14683 bacterial filtration efficiency context.
  • Uses biological or fluorescent tracers with reference samplers to compare capture performance, breakthrough, or device response.
Method fit depends on product geometry and claim language; non-mask devices often need a documented adaptation rationale.
ASTM F2101EN 14683

Setup configurations

Each device challenge begins by defining the target aerosol, device placement, and decision threshold. Before the first challenge run, the configuration establishes the release location, mixing strategy, reference sampler positions, environmental setpoints, replicate logic, device settings, and data-capture responsibilities. These details are documented in the study plan:

Device interfaces

Device-under-test placement in a chamber, duct, fixture, or inlet adapter with geometry photographed and recorded.

Flow & actuation profiles

Defined challenge airflow, device operating mode, and release timing; detector sampling cadence and internal logs captured when available.

Environmental controls

Temperature, RH, and background aerosol conditions logged before, during, and after each challenge sequence.

Sample numbers

Replicate challenges per condition plus blanks, background runs, and device-off controls sized to the decision risk.

Calibration & verification

Sampler flow, nebulizer output checks, assay controls, and environmental sensors verified within the study record.

Methods anchored to the standards that matter

The quality framework is selected based on the device class and the decision the data must support. ISO 17025 provides the accredited laboratory foundation. Applicable ASTM, EN, and 42 CFR frames are used as aligned methods when supported by the product category and claim.

  • ISO 17025AccreditedTesting-laboratory competence, traceable records, calibration control, and uncertainty contributors.
  • ASTM F2101AlignedBacterial filtration efficiency context for medical mask and barrier-device challenges.
  • ASTM F2299AlignedParticle penetration context for respirator media and filtration comparisons.
  • EN 149AlignedEuropean filtering half-mask context for aerosol penetration and classification studies.

Key data outputs & reporting

Device challenge aerosol reports relate the device response to a measured reference challenge, not only to the generator setting. Reported outputs include concentration estimates, response timing, alert calls, recovery checks, environmental logs, and the QA/QC records used to show where results are comparable, where they are fit for purpose, and how each conclusion was reached.

Primary outputs

  • Dose-response summary showing device signal, alert state, or capture result versus measured reference concentration.
  • Time-to-detect and alert-rate tables, including true positive, false positive, and false negative counts when the device output supports classification.
  • Reference sampler recovery, background, and blank results with qPCR, ddPCR, fluorescence, or particle-count endpoint details.
  • Environmental and flow logs tied to each challenge sequence, including RH, temperature, airflow, release timing, and device operating mode.

Deliverables

#FormatContents
01PDF reportMethods, controls, challenge conditions, response summaries, and conclusions.
02CSV / XLSX datasetsTime series, reference concentrations, alert calls, sampler recovery, and environmental logs.
03FiguresDose-response plots, time-to-detect distributions, and annotated challenge timelines.

QA / QC & data integrity

Each challenge study uses a documented QA/QC framework matched to the aerosol target, device class, and quantitation endpoint. Controls help separate the true device response from background, sampler recovery, assay variability, and environmental drift. Records are maintained under the ISO 17025 quality system from sample receipt through the final report.

Reference sampler blanks, background runs, and device-off controls included with every challenge sequence.

Replicate challenge runs and repeated sequences quantify run-to-run variability and response reliability.

Recovery verification for impingers, filters, extraction steps, and tracer assays where applicable.

Calibration and verification records for sampler flow, airflow, RH, temperature, and quantitation instruments.

Chain of custody for organisms, tracers, devices, collected samples, and extracted materials.

Why ARE Labs

ARE Labs connects technical topics to practical study design, method selection, controlled aerosol work, and reportable evidence without turning technical pages into sales pages.

Reviewed byJamie Balarashti (25 yrs - cascade & inhalation methods) - Weston Schaper (7 yrs - real-time sizing & nanoparticle work)
17025Accredited testing
900+Studies Performed
17+Years in operation
300+Clients supported

Common questions

These answers address common questions from bioaerosol detector teams, air-treatment developers, respiratory-protection programs, and medical-device teams planning a device challenge aerosol study. Topics include surrogate selection, concentration range, controls, time-to-detect outputs, applicable standards, reference quantitation, and deliverable formats. Contact ARE Labs if your device geometry, target aerosol, or regulatory frame differs from the examples below.

Q.Can you challenge with non-viable surrogates?
A.Yes. Fluorescent or biological tracers are commonly used when viability is not required. ARE Labs selects the surrogate based on the device response mechanism, biosafety requirements, and reference quantitation endpoint.
Q.How do you define the challenge concentration range?
A.ARE Labs brackets the expected detection threshold with challenge points above and below it to develop a response curve. The practical concentration range depends on the background level, sampling volume, and assay sensitivity.
Q.Do you provide ROC and time-to-detect metrics?
A.Yes, when the device output supports classification. Results can summarize time to detect, alert rate, sensitivity, false positives, and false negatives relative to measured reference concentrations.
Q.What controls are included?
A.Typical controls include device-off baselines, sampler blanks, background runs, and replicate challenge sequences. Recovery checks are included as needed for impingers, filters, extraction steps, and tracer assays.
Q.Which standards apply to my device?
A.The applicable framework depends on the product category. Respirator studies may align with EN 149 or 42 CFR Part 84, medical mask studies with ASTM F2101 or EN 14683, and sensor studies with ISO 17025 records.